1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1) : a multicentre, randomised, phase 2 trial
(
- Contribution to journal › Article
-
Mark
Impact of Neoadjuvant Therapy for Pancreatic Cancer : Transatlantic Trend and Postoperative Outcomes Analysis
(
- Contribution to journal › Article
- 2023
-
Mark
Sex and gender differences in treatment intention, quality of life and performance status in the first 100 patients with periampullary cancer enrolled in the CHAMP study
(
- Contribution to journal › Article
- 2022
-
Mark
Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article
-
Mark
Preoperative Risk Score for Early Mortality After Up-Front Pancreatic Cancer Surgery : A Nationwide Cohort Study
(
- Contribution to journal › Article
-
Mark
Risk factors and outcomes for patients with pancreatic cancer undergoing surgical exploration without resection due to metastatic disease : A national cohort study
(
- Contribution to journal › Article
- 2021
-
Mark
An analysis of gender differences in treatment and outcome of periampullary tumours in Sweden – A national cohort study
(
- Contribution to journal › Article
-
Mark
Organoid technology for personalized pancreatic cancer therapy
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
(
- Contribution to journal › Article
-
Mark
Expression of peritumoral SPARC during distal cholangiocarcinoma progression and correlation with outcome
(
- Contribution to journal › Article